Bayer Launches Multiple Sclerosis Fighter Betaferon In China
This article was originally published in PharmAsia News
Executive Summary
Bayer HealthCare China recently announced that it has gained approval for the launch in China of its Betaferon (interferon beta-1b), to treat relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis